Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
This study will be performed at Shahid Mohammadi Hospital in Bandar Abbas, Hormozgan in Iran. All positive (PCR confirmed) COVID-19 patients ≤65 years old who have Hb≤9 and at least one of the severe COVID-19 symptoms (tachypnea (breathing rate> 30 beats per minute), hypoxemia (O2 ≤93 saturation, the partial pressure ratio of arterial oxygen<300), Lung infiltration (> 50% of lung field within 24 to 48 hours), progressive lymphopenia, LDH>245 U/I, CRP>100) and are willing to cooperate in this project will be included in the study. Patients with a history of coronary heart disease, thrombosis, deep vein ...
Source: Trials - July 6, 2021 Category: Research Source Type: clinical trials
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Condition: Deep Venous Thrombosis Intervention: Drug: Enoxaparin Sponsors: Yale University; Children's Healthcare of Atlanta; Children's Hospital Colorado; Children's Hospital of Philadelphia; Virginia Commonwealth University; BJC HealthCare; Medical College of Wisconsin; Children's of Alabama; Children's Hospital Medical Cen ter, Cincinnati; Golisano Children's Hospital; Maria Fareri Children's Hospital; Nationwide Children's Hospital; New York Presbyterian Hospital; Penn State University; University of Iowa Not yet recruiting (Source...
Source: ClinicalTrials.gov - June 11, 2021 Category: Research Source Type: clinical trials
